Fluart Innovative Vaccines
Since 1991, we have played a prominent role in the Hungarian healthcare sector, covering 95% of the Hungarian flu market with our vaccines.
Hungary’s only pharmaceutical, biotechnology and life science research company that is a pioneer in influenza vaccine research and production. Through research development projects, we are constantly striving for innovation and development in the field of pharmaceutical and vaccine manufacturing, as well as in various other industries. We are constantly looking for solutions that go beyond treating disease: they have a positive impact on patients’ lives, on society and on science itself. As a Contract Contract Manufacturing Organisation (CDMO), we also provide integrated scientific services, from early discovery through to the production of preclinical/clinical trial samples.
History and heritage
The journey so far.
Founding our company as a national manufacturer in Hungary
Influenza vaccine production technology development and commissioning
Production of influenza vaccines begins
Trivalence – development of a three-component influenza vaccine
Successful development of standards for H5N1 reference virus reagents in collaboration with WHO during the avian influenza threat.
Pre- and pandemic vaccine development, licensing
Our products cover about 95% of the Hungarian flu vaccine market (public and pharmacy).
Entering the global market through export sales and Technology Transfer initiatives
The company has a BSL-3 (Bio-Safety Level 3) certified production site environment
Development and production of a new pandemic (H1N1) vaccine
First launched in Europe during the pandemic declared by the WHO